DLB Dolby Laboratories Inc

Price (delayed)

$82.5

Market cap

$7.91B

P/E Ratio

43.88

Dividend/share

$1.04

EPS

$1.88

Enterprise value

$7.32B

Dolby Laboratories is based in San Francisco with offices in over 20 countries around the globe. Dolby transforms the science of sight and sound into spectacular experiences. Through innovative research ...

Highlights
The debt has declined by 30% year-on-year and by 7% since the previous quarter
The EPS has declined by 25% year-on-year but it has grown by 2.2% since the previous quarter
DLB's price to earnings (P/E) is 20% higher than its last 4 quarters average of 36.4 but 6% lower than its 5-year quarterly average of 46.4
The net income has declined by 28% year-on-year
Dolby Laboratories's quick ratio has decreased by 23% YoY and by 2% QoQ

Key stats

What are the main financial stats of DLB
Market
Shares outstanding
95.82M
Market cap
$7.91B
Enterprise value
$7.32B
Valuations
Price to earnings (P/E)
43.88
Price to book (P/B)
3.46
Price to sales (P/S)
6.4
EV/EBIT
32.64
EV/EBITDA
22.68
EV/Sales
5.92
Earnings
Revenue
$1.24B
EBIT
$224.32M
EBITDA
$322.87M
Free cash flow
$302.52M
Per share
EPS
$1.88
Free cash flow per share
$3.15
Book value per share
$23.84
Revenue per share
$12.9
TBVPS
$23.7
Balance sheet
Total assets
$2.75B
Total liabilities
$456M
Debt
$47.42M
Equity
$2.29B
Working capital
$1.06B
Liquidity
Debt to equity
0.02
Current ratio
4.65
Quick ratio
4.37
Net debt/EBITDA
-1.81
Margins
EBITDA margin
26.1%
Gross margin
88.4%
Net margin
14.8%
Operating margin
17%
Efficiency
Return on assets
6.4%
Return on equity
7.7%
Return on invested capital
16.2%
Return on capital employed
9.1%
Return on sales
18.1%
Dividend
Dividend yield
1.26%
DPS
$1.04
Payout ratio
55.3%

DLB stock price

How has the Dolby Laboratories stock price performed over time
Intraday
0.54%
1 week
0.38%
1 month
-0.29%
1 year
9.56%
YTD
16.95%
QTD
16.95%

Financial performance

How have Dolby Laboratories's revenue and profit performed over time
Revenue
$1.24B
Gross profit
$1.09B
Operating income
$210.11M
Net income
$183.45M
Gross margin
88.4%
Net margin
14.8%
The net income has declined by 28% year-on-year
The net margin has declined by 28% year-on-year
Dolby Laboratories's operating income has decreased by 22% YoY
The operating margin has declined by 22% year-on-year but it rose by 3% since the previous quarter

Growth

What is Dolby Laboratories's growth rate over time

Valuation

What is Dolby Laboratories stock price valuation
P/E
43.88
P/B
3.46
P/S
6.4
EV/EBIT
32.64
EV/EBITDA
22.68
EV/Sales
5.92
The EPS has declined by 25% year-on-year but it has grown by 2.2% since the previous quarter
DLB's price to earnings (P/E) is 20% higher than its last 4 quarters average of 36.4 but 6% lower than its 5-year quarterly average of 46.4
DLB's price to book (P/B) is 15% higher than its last 4 quarters average of 3.0 and 11% higher than its 5-year quarterly average of 3.1
The equity has contracted by 13% YoY
DLB's price to sales (P/S) is 12% higher than its last 4 quarters average of 5.7 and 2.6% higher than its 5-year quarterly average of 6.2

Efficiency

How efficient is Dolby Laboratories business performance
Dolby Laboratories's return on invested capital has decreased by 27% YoY but it has increased by 3.2% QoQ
Dolby Laboratories's return on assets has decreased by 22% YoY
The company's return on equity fell by 21% YoY but it rose by 4.1% QoQ
The return on sales has declined by 20% year-on-year but it has grown by 5% since the previous quarter

Dividends

What is DLB's dividend history
DPS
$1.04
Dividend yield
1.26%
Payout ratio
55.3%
Recent dividends

Financial health

How did Dolby Laboratories financials performed over time
Dolby Laboratories's quick ratio has decreased by 23% YoY and by 2% QoQ
Dolby Laboratories's current ratio has decreased by 22% YoY
The debt is 98% smaller than the equity
Dolby Laboratories's debt to equity has decreased by 33% YoY
The debt has declined by 30% year-on-year and by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.